The emerging role of the PI3-K-Akt pathway in prostate cancer progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The emerging role of the PI3-K-Akt pathway in prostate cancer progression

Published:2005-02-22 Issue:2 Volume:8 Page:108-118
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Li L,Ittmann M M,Ayala G,Tsai M-J,Amato R J,Wheeler T M,Miles B J,Kadmon D,Thompson T C

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/4500776.pdf

Reference130 articles.

1. Blume-Jensen P, Hunter T . Oncogenic kinase signalling. Nature 2001; 411: 355–365.

2. Cantley LC . The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655–1657.

3. Nicholson KM, Anderson NG . The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002; 14: 381–395.

4. Paez J, Sellers WR . PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. Cancer Treat Res 2003; 115: 145–167.

5. Testa JR, Bellacosa A . AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 2001; 98: 10983–10985.

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer;Biomedicines;2022-04-05

2. Overview of the Development and Use of Akt Inhibitors in Prostate Cancer;Journal of Clinical Medicine;2021-12-29

3. Overview of Protein Kinase B Enzyme: A Potential Target for Breast and Prostate Cancer;Current Molecular Pharmacology;2021-08

4. Signalling transduction of O-GlcNAcylation and PI3K/AKT/mTOR-axis in prostate cancer;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2021-07

5. Investigation of spectroscopic and proteomic alterations underlying prostate carcinogenesis;Journal of Proteomics;2020-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3